Researchers led by investigators at Mass General Brigham have published valuable information about a rare but serious complication of anti-cancer immunotherapy, providing the first large-scale ...
MedPage Today on MSN
How much prednisone is too much in treating rheum effects from cancer therapies?
French study posits an answer ...
PHOENIX — Patients treated for cancer with immune checkpoint inhibitors (ICIs) who develop the drugs’ known side effects of diarrhea and colitis experience increased risk of adenomas in the colon — ...
A recent case report explains how epitope spread may cause immune checkpoint inhibitor (ICI)–associated bullous pemphigoid (BP). A separate research letter spotlights cases of partial lipodystrophy ...
GLP-1 RA use was also tied to lower rates of immune-related side effects, caused by the immune system becoming overactive as a result of immunotherapy treatment. Patients taking GLP-1 drugs showed ...
Efficacy and safety of nivolumab plus chemotherapy versus chemotherapy alone for the treatment of advance non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled ...
ICIs combined with chemotherapy showed higher efficacy than bevacizumab in treating advanced driver gene–negative NS-NSCLC. The study reported improved PFS and OS for patients receiving ICIs compared ...
New research has uncovered immune changes in cancer patients that could help identify which patients are most at risk of dangerous heart complications from cancer drugs, known as immune checkpoint ...
The medications most likely to cause thyroid eye disease are alemtuzumab, certain immune checkpoint inhibitors, amiodarone ...
Please provide your email address to receive an email when new articles are posted on . Patients who received PD-1 or PD-L1 agents exhibited increased risk for psoriasis. Medical professionals should ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results